Delivery Order SPE2DX15D9363-SPE2DX24F1MPY

Award Date 8/20/24
Potential Completion Date 9/11/24
Potential Value $53K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,575.14 contract is for the delivery of ILARIS 150 MG/ML VIALML, a pharmaceutical product, with a completion date of June 25, 2024. The contract is not associated with a set-aside program. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $26,575.14, is for the delivery of ILARIS 150 MG/ML VIALML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) under...
This is a $26,575.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ILARIS 150 MG/ML VIALML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is not associated with a set-aside program. DMS Pharmaceutical Group holds a larger $499,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $76,965.06, is for the delivery of ILARIS 150 MG/ML VIALML, a specialized pharmaceutical product. The contract has an ultimate completion date of February 4, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $12,827.51, is for the provision of ILARIS 150 MG/ML VIALML, a specialized pharmaceutical product. The contract has an ultimate completion date of February 12, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,287.57 contract is for the supply of ILARIS 150 MG/ML VIALML, a specialty pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a comprehensive...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $64,137.55, is for the delivery of ILARIS 150 MG/ML vials to support the recurring medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $26,575.14, is for the delivery of ILARIS 150 MG/ML VIALML, a specialized pharmaceutical product. The contract has no set-aside designation and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA...
This is a firm fixed-price delivery order (SPE2DB25FX1LH) awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $26,575.14 and covers the delivery of ILARIS 150 MG/ML vial, a specialized pharmaceutical product, with a completion date of November 26, 2024. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $25,655.02, is for the provision of ILARIS 150 MG/ML pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of branded and...
  • SPE2DX15D9363
    Indefinite Delivery Contract
  • SPE2DX15D9363-SPE2DX24F1MPY
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $53,150.28 contract is for the delivery of 4565562910 - ILARIS 150 MG/ML VIALML, with a period of performance through September 11, 2024.

DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. This contract serves as a prime vendor vehicle, complementing the company's other direct distribution contracts for prescription drugs and pharmacy services to Department of Defense (DoD) healthcare sites. The contract has no set-aside designation.

Generated 11/19/24, 9:12 AM